PharmaDoctor™ defend their position on rapid antibody tests

 

PharmaDoctor™ has responded to the recently published statement by the General Pharmaceutical Council (GPhC) advising pharmacy owners and superintendent pharmacists against the supply of COVID-19 rapid antibody tests through community pharmacy.

 

The response from PharmaDoctor™ in the form of an open letter to the GPhC is outlined below.

 

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

 

To access further supporting documents PharmaDoctor™ has asked that you contact them directly. You can access their website here.

 

Have your say and write to the editor. With your permission, we will publish your thoughts in our ‘letters to the editor’ section.

 

We'll use your email address only to get back in touch with you after filling in this form.

 

 

 

Published by

PIP editor

A pharmacist led training provider.

Leave a Reply

Your email address will not be published.